Damodarasamy, Mamatha
Vernon, Robert B.
Pathan, Jasmine L. https://orcid.org/0000-0003-1531-5307
Keene, C. Dirk https://orcid.org/0000-0002-5291-1469
Day, Anthony J. https://orcid.org/0000-0002-1415-3134
Banks, William A.
Reed, May J. https://orcid.org/0000-0002-6917-9286
Funding for this research was provided by:
National Institute on Aging (R03AG051071)
National Institutes of Health (R21AG056883)
National Institutes of Health (R01AG046619)
U.S. Department of Veterans Affairs
Klorfine Foundation
NIH (UL1 TR002319)
NIH (P50AG005136)
NIH (U01 AG006781)
Alvord Endowment
Article History
Received: 18 May 2020
Accepted: 9 September 2020
First Online: 29 September 2020
Ethics approval and consent to participate
: De-identified human brain issues are provided by the University of Washington Alzheimer’s Disease Research Center and the Adult Changes in Thought Study.
: Not applicable.
: Anthony J. Day is a Director of Link Biologics, which is focused on the use of a TSG-6-based biological drug for inflammatory conditions. The other authors have no conflict of interest to report.